Aaron Tward, M.D., Ph.D.

Scientific Co-Founder and Scientific Adviser

Aaron is an associate professor at the University of California, San Francisco (UCSF), and a scientific co-founder of Affinia Therapeutics. He is a surgeon-scientist and pioneer in the application of high-throughput sequencing technologies to critical problems in biomedicine. Aaron has authored more than 30 publications spanning the fields of genomics, cancer biology, stem cell biology, and skull base surgery. He received both a Ph.D. in biomedical sciences and an M.D. from UCSF and completed his residency in otolaryngology-head and neck surgery and fellowship in otology, neurotology, and skull base surgery at Harvard Medical School. He completed a post-doctoral fellowship at the Broad Institute of MIT and Harvard.